Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes.
Patricia Udaondo MireteAna Hervas-OntiverosAmir RosemblattSalvador Garcia-DelpechPublished in: Clinical ophthalmology (Auckland, N.Z.) (2021)
The results of this study confirmed previous evidence suggesting that DEX is effective for improving BCVA and CMT in patients with DME.